These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 6605980)
21. Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes. Nair MP; Schwartz SA J Immunol; 1982 Dec; 129(6):2511-8. PubMed ID: 6183335 [TBL] [Abstract][Full Text] [Related]
22. A human T cell-derived soluble factor able to suppress pokeweed mitogen-induced immunoglobulin production. Warrington RJ; Sauder PJ; Olivier SL; Rutherford WJ; Wilkins JA J Immunol; 1983 Jan; 130(1):237-41. PubMed ID: 6600180 [TBL] [Abstract][Full Text] [Related]
23. Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production. Fleisher TA; Greene WC; Blaese RM; Waldmann TA J Immunol; 1981 Mar; 126(3):1192-7. PubMed ID: 6450804 [TBL] [Abstract][Full Text] [Related]
24. Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression. Donnelly RP; La Via MF; Tsang KY Clin Exp Immunol; 1987 Jun; 68(3):488-99. PubMed ID: 3115647 [TBL] [Abstract][Full Text] [Related]
25. Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies. Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR; Goldstein AL; Lynch K Diagn Immunol; 1983; 1(3):168-73. PubMed ID: 6238750 [TBL] [Abstract][Full Text] [Related]
26. Activation of a suppressor T-cell pathway by interferon. Aune TM; Pierce CW Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3808-12. PubMed ID: 6179085 [TBL] [Abstract][Full Text] [Related]
27. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. Lane HC; Depper JM; Greene WC; Whalen G; Waldmann TA; Fauci AS N Engl J Med; 1985 Jul; 313(2):79-84. PubMed ID: 2582258 [TBL] [Abstract][Full Text] [Related]
28. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome. Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099 [TBL] [Abstract][Full Text] [Related]
29. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337 [TBL] [Abstract][Full Text] [Related]
30. Con A-induced suppressor cells in man. II. Role of monocytes and their interaction with soluble inhibitory factors. Mizerski J; Gajl-Peczalska K Immunobiology; 1981; 158(3):282-92. PubMed ID: 6452404 [TBL] [Abstract][Full Text] [Related]
31. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro. Fairchild RL; Moorhead JW J Immunol; 1986 Oct; 137(7):2125-31. PubMed ID: 2944949 [TBL] [Abstract][Full Text] [Related]
32. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease. Danis VA; Heatley RV Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515 [TBL] [Abstract][Full Text] [Related]
33. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens. Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848 [TBL] [Abstract][Full Text] [Related]
34. Soluble factor mediated T cell, B cell, and macrophage interactions in the regulation of the immune response in man. Warrington RJ; Wilkins JA Lymphokine Res; 1984; 3(3):137-44. PubMed ID: 6611468 [No Abstract] [Full Text] [Related]
35. Evidence for the presence of a low molecular-weight activator of suppressor monocytes (LASM) in dialysates of T lymphocytes. Nekam K; Strelkauskas AJ; Fudenberg HH; Donnan GG; Goust JM Immunology; 1981 May; 43(1):75-80. PubMed ID: 6972906 [TBL] [Abstract][Full Text] [Related]
36. Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes. Namba Y; Jegasothy BV; Waksman BH J Immunol; 1977 Apr; 118(4):1379-84. PubMed ID: 300407 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a soluble suppressor of human B cell function produced by a continuous human suppressor T cell line. II. Evidence for suppression through a direct action of CTC-SISS-B on human B cells. Greene WC; Fleisher TA; Depper JM; Leonard WJ; Stanton GJ; Waldmann TA J Immunol; 1982 Sep; 129(3):1120-3. PubMed ID: 6213708 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein. Wangel AG; Kontiainen S Clin Exp Immunol; 1983 Aug; 53(2):451-7. PubMed ID: 6192956 [TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity in the acquired immunodeficiency syndrome. de-Araujo AC Braz J Med Biol Res; 1987; 20(5):579-82. PubMed ID: 3452448 [TBL] [Abstract][Full Text] [Related]
40. IL 2 restores memory B cell activation by antigen-specific T cell clone variants. Ishihara T; Takahara S; Fathman CG J Immunol; 1986 Jan; 136(1):39-43. PubMed ID: 2415626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]